PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage

Annals of Neurology

Volumn 70, Issue 6, 2011, Pages 920-931

  Ma, Qingyi ^a   Huang, Bin ^a   Khatibi, Nikan ^b   Rolland II, William ^a   Suzuki, Hidenori ^a   Zhang, John H ^a,b   Tang, Jiping ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HIRUDIN; IMATINIB; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EXTRAVASATION; FUNCTION TEST; IMMUNOHISTOLOGY; IMMUNOPRECIPITATION; MOUSE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BASAL GANGLIA; BLOOD TRANSFUSION, AUTOLOGOUS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EVANS BLUE; GENE EXPRESSION REGULATION; IMIDAZOLES; METALLOENDOPEPTIDASES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PIPERAZINES; PYRIDINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIGNAL TRANSDUCTION; THROMBIN; TIME FACTORS;

EID: 84255196110     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22549     Document Type: Article

References (39)

1. Ribo M, Grotta JC,. Latest advances in intracerebral hemorrhage. Curr Neurol Neurosci Rep 2006; 6: 17-22. (Pubitemid 43154248)
2. He Y, Hua Y, Lee JY, et al. Brain alpha- and beta-globin expression after intracerebral hemorrhage. Transl Stroke Res 2010; 1: 48-56.
3. Keep RF, Xiang J, Ennis SR, et al. Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir Suppl 2008; 105: 73-77.
4. Heldin CH, Westermark B,. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79: 1283-1316. (Pubitemid 29473317)
5. Marx M, Perlmutter RA, Madri JA,. Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1994; 93: 131-139. (Pubitemid 24030829)
6. Su EJ, Fredriksson L, Geyer M, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008; 14: 731-737.
7. Yao H, Duan M, Buch S,. Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 2011; 117: 2538-2547.
8. Rynkowski MA, Kim GH, Komotar RJ, et al. A mouse model of intracerebral hemorrhage using autologous blood infusion. Nat Protoc 2008; 3: 122-128.
9. Garcia JH, Wagner S, Liu KF, Hu XJ,. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26: 627-634; discussion 635.
10. Wu B, Ma Q, Khatibi N, et al. Ac-YVAD-CMK decreases blood-brain barrier degradation by inhibiting caspase-1 activation of interleukin-1beta in intracerebral hemorrhage mouse model. Transl Stroke Res 2010; 1: 57-64.
11. Hua Y, Schallert T, Keep RF, et al. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 2002; 33: 2478-2484.
12. Seiffert E, Dreier JP, Ivens S, et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004; 24: 7829-7836. (Pubitemid 39215686)
13. Chen W, Hartman R, Ayer R, et al. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. J Neurochem 2009; 111: 726-736.
14. Strbian D, Durukan A, Tatlisumak T,. Rodent models of hemorrhagic stroke. Curr Pharm Des 2008; 14: 352-358. (Pubitemid 351522655)
15. Peggs K, Mackinnon S,. Imatinib mesylate-the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 2003; 348: 1048-1050. (Pubitemid 36302251)
16. Deininger MW, O'Brien SG, Ford JM, Druker BJ,. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 2003; 21: 1637-1647. (Pubitemid 46594119)
17. O'Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994-1004. (Pubitemid 36302244)
18. Dibb NJ, Dilworth SM, Mol CD,. Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nat Rev Cancer 2004; 4: 718-727. (Pubitemid 39215070)
19. Gehart H, Kumpf S, Ittner A, Ricci R,. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep 2010; 11: 834-840.
20. Zvalova D, Cordier J, Mesnil M, et al. p38/SAPK2 controls gap junction closure in astrocytes. Glia 2004; 46: 323-333. (Pubitemid 38679212)
21. Nito C, Kamada H, Endo H, et al. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2008; 28: 1686-1696.
22. Rosenberg GA, Navratil M,. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 1997; 48: 921-926.
23. Power C, Henry S, Del Bigio MR, et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 2003; 53: 731-742. (Pubitemid 36622510)
24. Tang J, Liu J, Zhou C, et al. Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab 2004; 24: 1133-1145. (Pubitemid 39332152)
25. Rosell A, Alvarez-Sabin J, Arenillas JF, et al. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Stroke 2005; 36: 1415-1420. (Pubitemid 40967504)
26. Cuadrado E, Rosell A, Penalba A, et al. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 2009; 8: 3191-3197.
27. Knauper V, Smith B, Lopez-Otin C, Murphy G,. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 1997; 248: 369-373. (Pubitemid 27387479)
28. Nakamura H, Fujii Y, Ohuchi E, et al. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 1998; 253: 67-75. (Pubitemid 28182306)
29. Chandrasekharan UM, Yang L, Walters A, et al. Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation. J Biol Chem 2004; 279: 46678-46685. (Pubitemid 39518315)
30. Lee KR, Colon GP, Betz AL, et al. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 1996; 84: 91-96. (Pubitemid 26007002)
31. Lee KR, Kawai N, Kim S, et al. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997; 86: 272-278. (Pubitemid 27130687)
32. Xi G, Wagner KR, Keep RF, et al. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke 1998; 29: 2580-2586. (Pubitemid 28544010)
33. Yang GY, Betz AL, Chenevert TL, et al. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg 1994; 81: 93-102. (Pubitemid 24195513)
34. Sarker KP, Yamahata H, Nakata M, et al. Recombinant thrombomodulin inhibits thrombin-induced vascular endothelial growth factor production in neuronal cells. Haemostasis 1999; 29: 343-352. (Pubitemid 30413222)
35. Matsuoka H, Hamada R,. Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention? CNS Drugs 2002; 16: 509-516. (Pubitemid 34827908)
36. Kitaoka T, Hua Y, Xi G, et al. Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage. Stroke 2002; 33: 3012-3018. (Pubitemid 35462880)
37. Xue M, Fan Y, Liu S, et al. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain 2009; 132 (Pt 1): 26-36.
38. Hursting MJ, Alford KL, Becker JC, et al. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor. Semin Thromb Hemost 1997; 23: 503-516. (Pubitemid 28114046)
39. Stenina OI, Shaneyfelt KM, DiCorleto PE,. Thrombin induces the release of the Y-box protein dbpB from mRNA: a mechanism of transcriptional activation. Proc Natl Acad Sci U S A 2001; 98: 7277-7282. (Pubitemid 32567939)